Navigation Links
Pathway for Veterans into the Biotech Industry
Date:5/9/2017

Swords to Plowshares, a San Francisco-based veteran service agency, has launched an employment initiative program to place veterans in careers within the emerging field of biotech.

Employment partnerships play an essential role in Swords to Plowshares' ability to increase employment opportunities for veterans. Through the program, Swords to Plowshares is working with Genentech and Genomic Health to provide veterans with a pathway of employment for careers in the growing field of biotech. The Swords to Plowshares Employment & Training team provides job brokering services to include: outreach and recruitment, screening and matching all qualified candidates with positions that best fit a veteran’s aptitude, experience, and geographic proximity to work, and assist with on-boarding services. These services streamline the process of hiring and provide employers with high quality veteran talent in their workforce.

“The Genentech Foundation is committed to supporting sustainable career pathways in biotech for the underserved. We are pleased to be working with leading veteran service agency, Swords to Plowshares, to increase employment opportunities for veterans in the biotech sector,” said Lakshmi Karan, executive director of the Genentech Foundation.

“Genomic Health Inc is proud to partner with Swords to Plowshares and the Genentech Foundation on the Veterans Biotech Hiring Initiative. Genomic Health values the service of our veterans and we want to ensure access to this group of talented individuals.” Kim McEachron, Chief People Officer at Genomic Health Inc.

Veterans will be hired to fill positions as Lab Service Technicians and Sample Accession Technicians. “These positions are intended to be stepping stones, with the ability to gain experience and move into other roles with greater responsibility within the field of biotech,” said Erica Trejo, Swords to Plowshares Employment and Training Director. “We are proud to partner with impactful community employers who recognize the benefits of hiring veterans for their workforce.”

About Swords to Plowshares:
Founded in 1974, Swords to Plowshares is a community-based not-for-profit organization that provides case management, mental health assessment and referral, rapid re-housing and eviction prevention services, employment and training, supportive housing, and legal benefits assistance for low-income, homeless and at-risk veterans in the San Francisco Bay Area. Swords to Plowshares promotes and protects the rights of veterans through advocacy, public education, and partnerships with local, state and national entities. Learn more about the work of Swords to Plowshares, and ways in which you can help, by visiting our website at http://www.stp-sf.org.

Read the full story at http://www.prweb.com/releases/veterans/pathway-into-biotech/prweb14315321.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
2. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
3. Metabolic Pathways Collection at SRI International the Largest in the World
4. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
5. Quantitative Profiling of the Intrinsic Pathway of Apoptosis in Tumor Tissue Using Myriad RBM’s Multiplex ApoptosisMAP™, a New Biomarker Webinar by Xtalks
6. American Farmer to Feature Pathway Biologic in Upcoming Episode
7. Pathway That Degrades Holiday Turkey Fuels Metastasis of Triple Negative Breast Cancer
8. HRA Reports Growing Number of Oncologists Following Clinical Pathways, Yet Standard Treatment Algorithms Exclude Some Cancer Drugs
9. Pathway's PowerBlend™ and PowerCoat™ = Powerful ROI for the Grower
10. MicroBiome Therapeutics Receives Positive Response From FDA For Use Of Expedited Regulatory Pathway For Diabetes Drug NM505
11. Rhythm Initiates Two Phase 2 Clinical Trials of Setmelanotide (RM-493) in Rare Genetic Disorders of Obesity Caused by MC4 Pathway Deficiencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... ... 11, 2017 , ... At its national board meeting in ... Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology ... in ARCS Alumni Hall of Fame . ASTER Labs is a technology ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):